Skip to content

THE EFFECT OF A GROUP OF AYURVEDIC MEDICINES ON SVITRA(VITILIGO) AMONG CHILDREN

TO EVALUATE THE ADD ON EFFICACY OF AROGYAVARDHINI VATI ALONG WITH DHATRYADI KASHAYA AND BAKUCHYADI LEPA IN THE MANAGEMENT OF SVITRA (VITILIGO) IN CHILDREN -A RANDOMIZED CLINICAL TRIAL.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042031
Enrollment
66
Registered
2022-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having Svitra patches with normal tactile sensation. 2. Patients with Twak svetata mandatorily, and preferably any or all of Roukshya, Kandu, Daha, Vivarnata (Roma) in the subjective symptom scoring. 3.Patients who are willing to participate in study.

Exclusion criteria

Exclusion criteria: 1. Patients not willing to participate in the study, and beyond the age range 8-16 years. 2. Lesion over the palms, genital & burnt areas. 3. Patients currently on other systems of medication or Ayurvedic medication. 4. Vitiligo associated with malignant melanoma, albinism and psoriasis. 5. Patient suffering from other systemic diseases (like bronchial asthma, URTI, etc.) & autoimmune disorders (Eg: Celiac disease, Type I Diabetes mellitus, Inflammatory Bowel Disease, etc.) which are Apatarpanajanya. 6.Patient with asadhya lakshana: A.Tridoshaja A. Involment of Gambhira dhatu (rakta , mamsa and meda) B. Agnidagdham and manifested in palms, soles, lips and genital organas C. Rakta loma D. Chirakari E. Patches are fused F. Janmataha

Design outcomes

Primary

MeasureTime frame
Reduction in subjective symptoms,Vitiligo Extensive Tensity Index score and increase in pigmentationTimepoint: 61ST AND 121TH DAYS

Secondary

MeasureTime frame
Improvement in Dermatological Life Quality IndexTimepoint: 61st day and 121st day

Countries

India

Contacts

Public ContactDr Rajagopala S

All India Institute of Sarita Vihar New Delhi

srajagopala@gmail.com7600902564

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026